Statistics

Total Visits

Views
Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice22

Select a period of time:

Number of views in the range

Views
Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice19

Views

Views
January 20250
February 20250
March 202515
April 20252
May 20252
June 20250
July 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
Brazil1
Chile1
Spain1
United States1
 

Top cities views

Views
Council Bluffs1
Petrópolis1